Evidence mapPaperPMID 40813985Full record

ReviewJournal of experimental & clinical cancer research : CR2025

TRP channels and cancer modulation: a voyage beyond metabolic reprogramming, oxidative stress and the advent of nanotechnologies in targeted therapy.

Marialaura Giannaccari, Chiara Florindi, Nora Bloise, Francesco Moccia, Francesco Lodola, Livia Visai

Abstract readReview
In one paragraph

Review in Journal of experimental & clinical cancer research : CR, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Marialaura GiannaccariMolecular Medicine Department (DMM), Centre for Health Technologies (CHT), Unità Di Ricerca (UdR) INSTM, Operative Unit (OU) of the Interuniversity Center for the Promotion of the 3Rs Principles in Teaching and Research (Centro 3R), University of Pavia, Pavia, 27100, Italy.
Chiara FlorindiDepartment of Biotechnology and Bioscience, University of Milano-Bicocca, Milan, 20126, Italy.
Nora BloiseMolecular Medicine Department (DMM), Centre for Health Technologies (CHT), Unità Di Ricerca (UdR) INSTM, Operative Unit (OU) of the Interuniversity Center for the Promotion of the 3Rs Principles in Teaching and Research (Centro 3R), University of Pavia, Pavia, 27100, Italy. nora.bloise@unipv.it.
Francesco MocciaDipartimento Di Medicina E Scienze Della Salute "V. Tiberio", Università Degli Studi del Molise, Campobasso, 86100, Italy.
Francesco LodolaDepartment of Biotechnology and Bioscience, University of Milano-Bicocca, Milan, 20126, Italy.
Livia VisaiMolecular Medicine Department (DMM), Centre for Health Technologies (CHT), Unità Di Ricerca (UdR) INSTM, Operative Unit (OU) of the Interuniversity Center for the Promotion of the 3Rs Principles in Teaching and Research (Centro 3R), University of Pavia, Pavia, 27100, Italy. livia.visai@unipv.it.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Transient receptor potential (TRP) channels are a large family of non-selective cation channels that play critical roles in cellular homeostasis and signal transduction. Recent investigations have clearly highlighted their involvement in cancer biology, particularly in the regulation of cancer metabolism. Unlike normal cells, cancer cells tend to favour the energy inefficient glycolytic pathway over the more effective oxidative phosphorylation process. TRP channels are involved in critical steps of cancer-related metabolic reprogramming by influencing intracellular Ca

Indexed as

NeoplasmsOxidative StressTransient Receptor Potential ChannelsAnimalsHumansMetabolic ReprogrammingMolecular Targeted TherapyNanotechnologyReactive Oxygen SpeciesReactive Oxygen SpeciesTransient Receptor Potential ChannelsCancerMetabolic reprogrammingNanotechnologiesOxidative stressTRP channels

Identifiers

PMID40813985
PMCPMC12351952

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.